145 related articles for article (PubMed ID: 10699306)
1. Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy.
Griffiths JR; Glickson JD
Adv Drug Deliv Rev; 2000 Mar; 41(1):75-89. PubMed ID: 10699306
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy.
Kato Y; Holm DA; Okollie B; Artemov D
Neuro Oncol; 2010 Jan; 12(1):71-9. PubMed ID: 20150369
[TBL] [Abstract][Full Text] [Related]
3. In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review.
Newell DR; Maxwell RJ; Golding BT
NMR Biomed; 1992; 5(5):273-8. PubMed ID: 1449968
[TBL] [Abstract][Full Text] [Related]
4. Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy.
van Laarhoven HW; Punt CJ; Kamm YJ; Heerschap A
Crit Rev Oncol Hematol; 2005 Dec; 56(3):321-43. PubMed ID: 15982898
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of radiolabelled anticancer drugs for positron emission tomography.
Hutchinson OC; Collingridge DR; Barthel H; Price PM; Aboagye EO
Curr Pharm Des; 2003; 9(11):917-29. PubMed ID: 12678875
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive 1H/13C magnetic resonance spectroscopic imaging of the intratumoral distribution of temozolomide.
Kato Y; Okollie B; Artemov D
Magn Reson Med; 2006 Apr; 55(4):755-61. PubMed ID: 16508914
[TBL] [Abstract][Full Text] [Related]
7. Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours.
McSheehy PM; Port RE; Rodrigues LM; Robinson SP; Stubbs M; van der Borns K; Peters GJ; Judson IR; Leach MO; Griffiths JR
Cancer Chemother Pharmacol; 2005 Feb; 55(2):117-28. PubMed ID: 15592719
[TBL] [Abstract][Full Text] [Related]
8. 19F MRS studies of fluoropyrimidine chemotherapy. A review.
McSheehy PM; Griffiths JR
NMR Biomed; 1989 Nov; 2(4):133-41. PubMed ID: 2701569
[TBL] [Abstract][Full Text] [Related]
9. Development and applications of in vivo clinical magnetic resonance spectroscopy.
Cox IJ
Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the 13C labeled anticancer agent temozolomide detected in vivo by selective cross-polarization transfer.
Artemov D; Bhujwalla ZM; Maxwell RJ; Griffiths JR; Judson IR; Leach MO; Glickson JD
Magn Reson Med; 1995 Sep; 34(3):338-42. PubMed ID: 7500872
[TBL] [Abstract][Full Text] [Related]
11. Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.
Baker SD; Verweij J; Rowinsky EK; Donehower RC; Schellens JH; Grochow LB; Sparreboom A
J Natl Cancer Inst; 2002 Dec; 94(24):1883-8. PubMed ID: 12488482
[TBL] [Abstract][Full Text] [Related]
12. Using metabolomics to monitor anticancer drugs.
Chung YL; Griffiths JR
Ernst Schering Found Symp Proc; 2007; (4):55-78. PubMed ID: 18811053
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive MRS in new anticancer drug development.
Workman P; Maxwell RJ; Griffiths JR
NMR Biomed; 1992; 5(5):270-2. PubMed ID: 1449967
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma.
Delgado-Goñi T; Julià-Sapé M; Candiota AP; Pumarola M; Arús C
NMR Biomed; 2014 Nov; 27(11):1333-45. PubMed ID: 25208348
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy: a powerful tool for drug metabolism studies.
Malet-Martino MC; Martino R
Biochimie; 1992; 74(9-10):785-800. PubMed ID: 1467338
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
17. Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs.
Hanusovská E; Dovinová I; Tkác I; Novotný L
Neoplasma; 1998; 45(4):187-97. PubMed ID: 9890660
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study for clinical pharmacokinetics of oral fluorine anticancer medicines using the commercial MRI system 19F-MRS.
Ikehira H; Girard F; Obata T; Ito H; Yoshitomi H; Miyazaki M; Nakajima N; Kamei H; Kanazawa Y; Takano H; Ito H; Tanada S; Sasaki Y
Br J Radiol; 1999 Jun; 72(858):584-9. PubMed ID: 10560341
[TBL] [Abstract][Full Text] [Related]
19. [Application of multinuclear in vivo magnetic resonance spectroscopy in oncology].
Semmler W; Gückel F; Bachert-Baumann P; Lorenz WJ; van Kaick G
Radiologe; 1989 Jul; 29(7):330-5. PubMed ID: 2667032
[TBL] [Abstract][Full Text] [Related]
20. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
